Skip to content

Ultrasound-guided selective cervical nerve root block for cervical radicular pain: a prospective study of anesthetic combination with neurotropin or steroid

Ultrasound-guided selective cervical nerve root block for cervical radicular pain: a prospective study of anesthetic combination with neurotropin or steroid

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082698
Enrollment
Unknown
Registered
2024-04-03
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical radicular pain

Interventions

steroid injection group:Local anesthetic (0.5% lidocaine 1 ml) solution combined with dexamethasone is injected for therapeutic block.
neurotropin injection group:Local anesthetic (0.5% lidocaine 1 ml) solution combined with neurotropin is injected for therapeutic block.

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All the patients diagnosed with cervical radicular pain were reviewed. The patients all received selective cervical nerve root block by steroid or neurotropin under the guidance of ultrasound. The inclusion criteria are as follows: 1) one-sided cervical radicular pain and lasted for more than 1 month; 2) magnetic resonance imaging showing a close relation to the symptoms; 3) pain intensity =40 mm on the visual analogue scale (VAS); 4) 18 years = age =70 years; 5) patients are able to sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients with the following conditions were ruled out: 1) spinal compression or myelopathy; 2) allergy to steroids or local anesthetics or neurotropin; 3) previous spinal surgery or treatment with selective nerve root block; 4) pregnant women; 5) coagulation abnormality; 6) patients who unable to complete the questionnaire; 7) patients with pain, which is caused by malignant or autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Pain assessment;

Secondary

MeasureTime frame
Evaluation of treatment effects;Depression assessment;Adverse events;Pain degree;Life quality;

Countries

CHINA

Contacts

Public ContactXiangrui Wang

Shanghai East Hospital

xiangrui68@163.com+86 137 0190 1953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026